In a move that has concerned the pharmaceutical industry, the El Salvadoran health and economy ministers reportedly want to change existing law to allow the government to issue compulsory licenses for medicines used to combat non-communicable diseases, such as diabetes and cancer.

By doing so, the government would be able to “react to cases of epidemics, prevalent diseases, and public health crises in a timely manner,” Giovannia Guevara, director of health technologies in the Health Ministry, told El Mundo. The reform “will give us additional tools to those we already have to defend the population’s right to health.” Guevara did not respond to a request for comment.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy